{"transactions":[{"id":711759,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-07-10T00:47:24.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. McLaughlin for services performed on the Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 7/9/2027, 7/9/2028 and 7/9/2029, or upon change of control."}],"balance_after":30001,"derivative":{"exercise_price":1.26,"expiration_date":"2036-07-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-26-005421","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316826005421/ownership.xml","form_type":"4"}},{"id":955010,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-01-02T22:22:56.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. McLaughlin for services performed on the Board of Directors as part of the Company's annual grant of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 1/2/2027, 1/2/2028 and 1/2/2029, or upon change of control."}],"balance_after":20001,"derivative":{"exercise_price":3.68,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-26-000036","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316826000036/ownership.xml","form_type":"4"}},{"id":1314010,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-01-03T22:02:08.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. McLaughlin for services performed on the Board of Directors as part of the Company's annual grant of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 1/2/2026, 1/2/2027 and 1/2/2028, or upon change of control."}],"balance_after":10044,"derivative":{"exercise_price":2.68,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001683168-25-000082","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316825000082/ownership.xml","form_type":"4"}},{"id":2074123,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-12-30T22:01:13.000Z","date":"2022-12-29","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. McLaughlin for services performed on the Board of Directors as part of the Company's annual grant of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 12/29/2023, 12/29/2024 and 12/29/2025, or upon change of control."}],"balance_after":53252,"derivative":{"exercise_price":1.08,"expiration_date":"2032-12-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001683168-22-008718","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316822008718/ownership.xml","form_type":"4"}},{"id":2434712,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-01-15T01:32:39.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. McLaughlin for services performed on the Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 10,000 each on 07/14/2022, 07/14/2023 and 07/14/2024, or upon change of control."}],"balance_after":33252,"derivative":{"exercise_price":4.6,"expiration_date":"2032-01-14","underlying":"Common stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-22-000277","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316822000277/ownership.xml","form_type":"4"}},{"id":3910448,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-06-02T00:30:54.000Z","date":"2018-05-30","kind":"grant","acquired":true,"shares":1781,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":48728,"source":{"system":"sec-edgar","filing":"0001683168-18-001580","document":"mclaughlin_frm4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316818001580/mclaughlin_frm4.xml","form_type":"4"}},{"id":4019475,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-03-03T00:02:06.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":1958,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":46947,"source":{"system":"sec-edgar","filing":"0001683168-18-000569","document":"mclaughlin_f4-030118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316818000569/mclaughlin_f4-030118.xml","form_type":"4"}},{"id":4110907,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-01-04T02:41:58.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":17211,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a bonus for services and vests immediately."}],"balance_after":44989,"source":{"system":"sec-edgar","filing":"0001683168-18-000039","document":"mclaughlin_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316818000039/mclaughlin_f4.xml","form_type":"4"}},{"id":4145908,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2017-12-01T21:41:06.000Z","date":"2017-11-29","kind":"grant","acquired":true,"shares":14317,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer as well as an annual grant pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":27778,"source":{"system":"sec-edgar","filing":"0001683168-17-003206","document":"mclaughlin_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316817003206/mclaughlin_f4.xml","form_type":"4"}},{"id":4221422,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2017-08-30T22:57:20.000Z","date":"2017-08-29","kind":"grant","acquired":true,"shares":1210,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":13471,"source":{"system":"sec-edgar","filing":"0001683168-17-002261","document":"mclaughlin_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316817002261/mclaughlin_f4.xml","form_type":"4"}},{"id":4297829,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2017-06-01T12:30:59.000Z","date":"2017-05-30","kind":"grant","acquired":true,"shares":1036,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":12261,"source":{"system":"sec-edgar","filing":"0001683168-17-001459","document":"mclaughlin_frm4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316817001459/mclaughlin_frm4.xml","form_type":"4"}},{"id":4408823,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2017-03-02T21:07:10.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":976,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":11225,"source":{"system":"sec-edgar","filing":"0001683168-17-000480","document":"mclaughlin_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316817000480/mclaughlin_f4.xml","form_type":"4"}},{"id":4408822,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2017-03-02T21:07:10.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":2250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as an annual grant pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":10249,"source":{"system":"sec-edgar","filing":"0001683168-17-000480","document":"mclaughlin_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316817000480/mclaughlin_f4.xml","form_type":"4"}},{"id":4538521,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2016-11-30T22:02:58.000Z","date":"2016-11-29","kind":"grant","acquired":true,"shares":1423,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":7999,"source":{"system":"sec-edgar","filing":"0001683168-16-000816","document":"mclaughlin_frm4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316816000816/mclaughlin_frm4.xml","form_type":"4"}}]}